1. (a) In accordance with RSA 151:33, II, all hospitals shall identify, track, and report infections, including:

   1. (1) Catheter-associated urinary tract infections;
   2. (2) Central line related bloodstream infections; and
   3. (3) Surgical wound infections.
2. (b) All hospitals shall provide to the department Clostridioides difficile infection (CDI) labID event data, if available.

3. (c) Hospitals shall also identify, track, and report process measures including:

   1. (1) Coverage rates of influenza vaccination for health care personnel and patients or residents; and
   2. (2) Antimicrobial use data, if available.
4. (d) In accordance with RSA 151:33, II-a, all ambulatory surgical centers shall identify, track, and report surgical wound infections.

5. (e) Ambulatory surgical centers shall also identify, track, and report on the following:

   1. (1) Surgical antimicrobial prophylaxis administered intravenously; and
   2. (2) Coverage rates of influenza vaccination for health care personnel.

6. (f) In accordance with RSA 151:33, II-b, all end-stage renal dialysis centers shall identify, track, and report dialysis events, including:

   1. (1) Positive blood cultures; and
   2. (2) Vascular access site infections.

7. (g) End stage renal dialysis centers shall also identify, track, and report on the following:

   1. (1) Intravenous antimicrobial start time; and
   2. (2) Coverage rates of influenza vaccination of health care personnel.
8. (h) In accordance with RSA 151:33, II-c, the New Hampshire veterans’ home and all nursing homes, residential care facilities, and assisted living facilities shall identify, track, and report coverage rates of influenza vaccination of health care personnel.

Source. #9851, eff 1-14-11; ss by #10079, eff 1-26-12; ss by #12943, eff 12-11-19; amd by #13282, INTERIM, eff 10-23-21; ss by #13351, eff 3-19-22 (see Revision Note at part heading for He-P 309)